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ABSTRACT
Congenital erythropoietic porphyria (CEP) is an extremely rare disorder involved in chronic porphyrias. One of
the recommended evaluations to determine disease severity and needs of a person with CEP is dental assessment.
Objective: To present a case of CEP and its oral rehabilitation. Case Report: A 32-year-old female patient was
admitted to the clinic with hyperkeratinization, skin fragility, fissures, and wounds in her perioral region and hands.
Intraoral gingival bleeding, mucogingival stress, and missing teeth were recorded. After medical consultation, phase
I and II periodontal therapies were performed. The patient expressed satisfaction of the results of the procedures
in terms of the parameters evaluated. The rare occurrence of the disease may delay the diagnosis. An unmet need
still exists for multidisciplinary orientation of patients with CEP. Conclusion: Dentists should have and follow
guidelines for treating patients with CEP.
Key words: congenital erythropoietic porphyria, oral health promotion, porphyria, rehabilitation
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INTRODUCTION

CEP demonst rates unique dental-craniofacial
symptoms in the early phase of the disease. Therefore,
dentists may be the first healthcare providers to define
this disease at an early stage. To achieve this, dentists
should have sufficient knowledge of the relevant
clinical features of CEP.10

Porphyrias form a group of hereditary metabolic
disorders caused by defects in the biosynthesis of
heme and are categorized as hepatic or erythropoietic.
Congenital erythropoietic porphyria (CEP) is an
extremely rare disorder involving erythropoietic
porphyrias and results from the insufficient activity
of the fourth enzyme that belongs to the heme
biosy nthetic pathway, which is coded by the
uroporphyrinogen III synthase gene.1-3 Its symptoms
include photosensitivity owing to massive porphyrin
accumulation in the skin (subepidermal blistering
with inflammatory infiltration)4, mild to severe anemia
(resulting from induced osmotic hemolysis with the
extreme accumulation of porphyrin in erythroid
precursors, reticulocytes, and erythrocytes),5 ocular
complications (corneal scarring, ulcerative keratitis,
and conjunctivitis),6-8 hyperpigmentation,9 facial scars,
reddish-brown discoloration in the teeth, and sclerotic
and osteolytic round lesions in the skull and jaws.10

This report presents the clinical, dermatological, and
laboratory findings as well as the oral rehabilitation of
a patient with CEP having periodontal problems and
missing teeth.
CASE REPORT
A 32-year-old female patient was admitted to the
Department of Periodontology, Faculty of Dentistry,
Necmettin Erbakan University because of gingival
bleeding and missing teeth on consultation to another
dentist. The patient’s medical history revealed her
previous diagnosis of CEP. The patient did not take
any medication. Porphyria was not reported in the
98
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Figure 2. (A) Thickening of the stratum corneum layer,
increased collagen tissue in the dermis, and proliferation
of the vessels (hematoxylin and eosin staining, 100×). (B)
PAS-positive reaction in the vessel wall (arrow) (PAS, 100×).

Figure 1. Dermatological signs of porphyria were observed
in the patient.

In the biopsy for distinction from scleroderma, thick
hyperkeratosis on the epidermis surface, pigment
incontinence in the superficial dermis, capillary
proliferation, prominence in some vessel walls,
perivascular rare lymphocytes, and increase in collagen
fibers have been detected in histological sections
(Figure 2A). Compared to scleroderma, the collagen
had looser texture. In the histochemical examination,
although not conspicuous, PAS-positive deposition in
some vessel walls has been detected (Figure 2B), and
this was considered compatible with porphyria rather
than scleroderma.

patient’s family and first-degree relatives. Moreover,
the patient did not have regular dental examinations;
thus, consultation was requested.
Dermatological and laboratory ﬁndings
T he fol low i ng sig n s we r e ob s e r ve d d u r i ng
dermatological examination: diffuse alopecia and
minimal cicatricial alopecia; facial discoloration,
increased telangiectasias, and erythema; cheilitis,
erosion, and rhagades of the lips; increased erythema
and pigmentation on the neck and body, xerosis, and skin
thinning (dermatrophy); erythema hyperpigmentation,
xerosis, and dermatrophy on hands and feet; rhagades,
atrophy, and keratosis (hardening) in the palms; and nail
discoloration, onychodystrophy, and xerophthalmia.
Dermatological signs are shown in Figure 1.

Oral examination
The clinical examination revealed hyperkeratinization,
skin fragility, fissures, and wounds in the perioral
region. In addition, the edges of the patient’s lips
tended to rupture. The patient was found to be sensitive
to sunlight. She used a moisturizer to minimize this
sensitivity.

In the laboratory examination, ANA and anti-ds DNA
were negative, and mild hemolytic anemia, increased
IgM level (2.66 g/L [0.4–2.3 g/L]), and mild hemolytic
anemic peripheral spreading were determined. In the
patient’s urine, levels of creatinine, porphobilinogen,
uroporphyrins 1 and 3, coproporphyrins 1 and 3, heptacarboxyl porphyrin, hexa-carboxyl porphyrin, and
total porphyrin amounts were normal. In radiological
examination, no pathology has been detected in the
spleen and viscera.

The patient could not open her mouth widely, and
she had 18 permanent teeth as seen during intraoral
examination. Each quad rant was ter minating
edentulous, and no vestibule sulcus depth was seen
in the posterior region. In addition, edematous
gingiva, hyperemia, bleeding on probing, and plaque
accumulation were observed (Figure 3); she was then
diagnosed with periodontitis.11 The patient did not felt
any pain in the gingiva during probing. Mucogingival
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Figure 3. Preoperative intraoral view of the patient showed
edematous gingiva, hyperemia, bleeding on probing, and
plaque accumulation.

Figure 5. Vestibuloplasty procedures in the (A) maxilla
and (B) mandible.The periodontal status of the patient was
reevaluated, and with a diode laser, vestibuloplasty of the
maxilla and mandible was performed under local anesthesia

Figure 4. Radiographic view of the patient showed alveolar
bone loss around the remaining teeth and reduced bone height
in the posterior edentulous sites; no periapical pathology.

stress was observed in the anterior region of the
maxilla and premolars in the mandible due to shallow
vestibular depth and inadequate keratinized tissue
band. Moreover, gingival recession of the left central
tooth in the maxilla was observed.

Figure 6. Clinical view two weeks after dental treatment.

Radiographic evaluation showed alveolar bone loss
around the remaining teeth and reduced bone height in
the posterior edentulous sites; no periapical pathology
was observed (Figure 4). The patient was consulted for
prosthetic treatment due to missing teeth. To obtain
functional and aesthetic result, planning was done with
the prosthodontist before treatment.

provide oral hygiene because she could not place the
brush properly. On the day of surgery, the periodontal
status of the patient was reevaluated, and with a diode
laser, vestibuloplasty of the maxilla and mandible
was performed under local anesthesia (Figure 5).
The involved areas were closed with a eugenol-free
periodontal dressing to ensure postoperative comfort.
The patient was informed about postoperative care
and prescribed flurbiprofen (100 mg tb, S.2X1) and
chlorhexidine mouthwash. An appointment was made
after 1 week to monitor healing. On the appointment
day, the periodontal dressing was gently removed. The
healing was uneventful, and the patient was asked to
brush the operated areas gently.

Treatment
The patient was informed about the procedures to be
performed, and she provided informed consent. The
patient first consulted a physician for the procedures
to be performed in the clinic. After consultation, each
quadrant was debrided periodontally with ultrasonic
and Gracey instruments (scaling and root planing).
Then, the patient was informed about oral hygiene.
Comfortable dental treatment was not possible owing
to the fragility of the rigid lips, but the patient indicated
that the postoperative pain was tolerable. The oral
hygiene was strengthened during examinations.

At four weeks after the operation, the construction of a
removable denture was started, and oral rehabilitation
was completed two weeks later (Figure 6). Postoperative
comfort, function, and aesthetic satisfaction were
evaluated in control examinations, and the patient
expressed satisfaction of the results of the procedures.

An appointment for periodontal surgery was made for
shallow vestibular sites where the patient could not
100
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DISCUSSION

Insufficient visual area may cause mild pain and
discomfort inevitably, and the quality of life of the
patient is adversely affected during the postoperative
period. CEP is a multisystemic disorder. In addition
to hematologic complications, cutaneous, ocular, oral,
and skeletal fi ndings contribute to determining the
severity of disease and health-related quality of life.7
The influence on the quality of life also affects the
outcome and success of treatment.

Dermatological diseases and syndromes are often
diagnosed by deter mining systemic signs and
symptoms. Dental pathology is observed in a number of
dermatological disorders, but it is often overlooked. A
number of dermatological skin diseases and syndromes
are associated with dental signs and periodontal
pathology.12 Assessment of specific dental signs related
to CEP may be helpful in diagnosis.13 Although CEP
is an extremely rare metabolic disorder, it is still
encountered clinically. We believed that the present
report may be useful for clinicians owing to the few
studies available in the literature on dental assessment
of patients with CEP.

CONCLUSION
In conclusion, we recommend the following to achieve
optimal success in the dental treatment of a patient with
CEP. Firstly, it is a necessity of a multidisciplinary
cooperation between family physicians, dermatologists,
and porphyria specialists is essential for the diagnosis
and management of porphyria,15 the patient should
consult a physician to perform optimal treatment.16
Secondly, cooperation with the patient is important, the
patient must be informed about the planned operations,
and the expectations must be answered. Thirdly, if the
mouth width is limited, using a soft child toothbrush
or an electric toothbrush may help provide the best
possible oral hygiene,17 and dental visits at least two
times a year are a must to maintain a healthy oral status.

To provide optimal treatment in patients with
porphyria, dentists should be in dialogue with the
patient’s physician. As management of patients with
porphyrias, pharmacological concerns have been
considered important. Drugs have been categorized
according to their porphyrinogenic potential: safe or
likely safe, unsafe or likely unsafe, and unclear.14 In
the present case, planned operations were discussed
with the physician. As a result of the consultation, the
relevance of the planned procedures was confirmed,
and no further recommendations were made by the
physician.
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had good oral hygiene, and vestibuloplasty under
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